Found: 11
Select item for more details and to access through your institution.
Dexamethasone as a chemoprotectant in cancer chemotherapy: hematoprotective effects and altered pharmacokinetics and tissue distribution of carboplatin and gemcitabine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 6, p. 459, doi. 10.1007/s00280-003-0759-9
- By:
- Publication type:
- Article
Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 6, p. 468, doi. 10.1007/s00280-003-0758-x
- By:
- Publication type:
- Article
The effects of degree of hepatic or renal impairment on the pharmacokinetics of exemestane in postmenopausal women.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 6, p. 482, doi. 10.1007/s00280-004-0769-2
- By:
- Publication type:
- Article
A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 6, p. 489, doi. 10.1007/s00280-004-0762-9
- By:
- Publication type:
- Article
Investigations on the pharmacokinetics of trofosfamide and its metabolites—first report of 4-hydroxy-trofosfamide kinetics in humans.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 6, p. 496, doi. 10.1007/s00280-003-0757-y
- By:
- Publication type:
- Article
Population pharmacokinetics of melphalan, infused over a 24-hour period, in patients with advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 6, p. 503, doi. 10.1007/s00280-003-0761-2
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 6, p. 519, doi. 10.1007/s00280-004-0767-4
- By:
- Publication type:
- Article
Plasma and cerebrospinal fluid pharmacokinetic study of BNP1350 in nonhuman primates.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 6, p. 527, doi. 10.1007/s00280-004-0765-6
- By:
- Publication type:
- Article
Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 6, p. 533, doi. 10.1007/s00280-003-0760-3
- By:
- Publication type:
- Article